Genetic Strain Differences in Learned Fear Inhibition Associated with Variation in Neuroendocrine, Autonomic, and Amygdala Dendritic Phenotypes
Overview
Authors
Affiliations
Mood and anxiety disorders develop in some but not all individuals following exposure to stress and psychological trauma. However, the factors underlying individual differences in risk and resilience for these disorders, including genetic variation, remain to be determined. Isogenic inbred mouse strains provide a valuable approach to elucidating these factors. Here, we performed a comprehensive examination of the extinction-impaired 129S1/SvImJ (S1) inbred mouse strain for multiple behavioral, autonomic, neuroendocrine, and corticolimbic neuronal morphology phenotypes. We found that S1 exhibited fear overgeneralization to ambiguous contexts and cues, impaired context extinction and impaired safety learning, relative to the (good-extinguishing) C57BL/6J (B6) strain. Fear overgeneralization and impaired extinction was rescued by treatment with the front-line anxiety medication fluoxetine. Telemetric measurement of electrocardiogram signals demonstrated autonomic disturbances in S1 including poor recovery of fear-induced suppression of heart rate variability. S1 with a history of chronic restraint stress displayed an attenuated corticosterone (CORT) response to a novel, swim stressor. Conversely, previously stress-naive S1 showed exaggerated CORT responses to acute restraint stress or extinction training, insensitivity to dexamethasone challenge, and reduced hippocampal CA3 glucocorticoid receptor mRNA, suggesting downregulation of negative feedback control of the hypothalamic-pituitary-adrenal axis. Analysis of neuronal morphology in key neural nodes within the fear and extinction circuit revealed enlarged dendritic arbors in basolateral amygdala neurons in S1, but normal infralimbic cortex and prelimbic cortex dendritic arborization. Collectively, these data provide convergent support for the utility of the S1 strain as a tractable model for elucidating the neural, molecular and genetic basis of persistent, excessive fear.
Toorie A, Hall C, Vassoler F, Peltz G, Byrnes E Psychopharmacology (Berl). 2024; 241(7):1435-1446.
PMID: 38503843 DOI: 10.1007/s00213-024-06574-0.
Single-cell methylation analysis of brain tissue prioritizes mutations that alter transcription.
Flint J, Heffel M, Chen Z, Mefford J, Marcus E, Chen P Cell Genom. 2023; 3(12):100454.
PMID: 38116123 PMC: 10726494. DOI: 10.1016/j.xgen.2023.100454.
Ryherd G, Bunce A, Edwards H, Baumgartner N, Lucas E Horm Behav. 2023; 156:105439.
PMID: 37813043 PMC: 10810684. DOI: 10.1016/j.yhbeh.2023.105439.
The effect of SSRIs on fear learning: a systematic review and meta-analysis.
Heesbeen E, Bijlsma E, Verdouw P, van Lissa C, Hooijmans C, Groenink L Psychopharmacology (Berl). 2023; 240(11):2335-2359.
PMID: 36847831 PMC: 10593621. DOI: 10.1007/s00213-023-06333-7.
CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences.
Ten-Blanco M, Pereda-Perez I, Izquierdo-Luengo C, Berrendero F Front Pharmacol. 2022; 13:975020.
PMID: 36081934 PMC: 9445237. DOI: 10.3389/fphar.2022.975020.